1. Facile fluorescent aptasensor using aggregation-induced emission luminogens for exosomal proteins profiling towards liquid biopsy
    Bo Li et al, 2020, Biosensors and Bioelectronics CrossRef
  2. Landscape Analysis of Matrix Metalloproteinases Unveils Key Prognostic Markers for Patients With Breast Cancer
    Tianyi Cheng et al, 2022, Frontiers in Genetics CrossRef
  3. Raman spectroscopy of serum: A study on ‘pre’ and ‘post’ breast adenocarcinoma resection in rat models
    Tanmoy Bhattacharjee et al, 2015, Journal of Biophotonics CrossRef
  4. Discovering cancer biomarkers from clinical samples by protein microarrays
    Bin Hu et al, 2015, PROTEOMICS – Clinical Applications CrossRef
  5. Serum immuno-oncology markers carry independent prognostic information in patients with newly diagnosed metastatic breast cancer, from a prospective observational study
    Frida Björk Gunnarsdottir et al, 2023, Breast Cancer Research CrossRef
  6. A microRNA Signature Associated with Early Recurrence in Breast Cancer
    Luis G. Pérez-Rivas et al, 2014, PLoS ONE CrossRef
  7. Postoperative serum Vascular Endothelial Growth Factor is an independent prognostic factor of disease free survival and overall survival in patients with non metastatic colon cancer
    M. Pascual et al, 2018, The American Journal of Surgery CrossRef
  8. Diagnostic power of VEGF, MMP-9 and TIMP-1 in patients with breast cancer. A multivariate statistical analysis with ROC curve
    Monika Zajkowska et al, 2019, Advances in Medical Sciences CrossRef
  9. The Breast Cancer to Bone (B2B) Metastases Research Program: a multi-disciplinary investigation of bone metastases from breast cancer
    Nigel T. Brockton et al, 2015, BMC Cancer CrossRef
  10. Matrix Metalloproteinase 1 Acts as an Independent Prognostic Biomarker Correlated with Immune Infiltration in Breast Cancer
    Yilin Li et al, 2024, Journal of Biomedical Nanotechnology CrossRef
  11. Biobanking in the Twenty-First Century: Driving Population Metrics into Biobanking Quality
    Joseph N. Roberts et al, 2015, Biobanking in the 21st Century CrossRef
  12. Plasma levels and diagnostic utility of VEGF, MMP-2 and TIMP-2 in the diagnostics of breast cancer patients
    Sławomir Ławicki et al, 2017, Biomarkers CrossRef
  13. Immediate Postoperative Inflammation Is an Important Prognostic Factor in Breast Cancer
    Se Kyung Lee et al, 2015, Oncology CrossRef
  14. Perioperative Inflammation as Triggering Origin of Metastasis Development
    Michael W. Retsky et al, 2017, Perioperative Inflammation as Triggering Origin of Metastasis Development CrossRef
  15. Mendelian randomization analyses of genetically predicted circulating levels of cytokines with risk of breast cancer
    Shen Li et al, 2020, npj Precision Oncology CrossRef
  16. In Situ Detection of Plasma Exosomal MicroRNA-1246 for Breast Cancer Diagnostics by a Au Nanoflare Probe
    Ling-Yan Zhai et al, 2018, ACS Applied Materials & Interfaces CrossRef
  17. Plasma levels and diagnostic utility of MMP-2 and TIMP-2 in the diagnosis of Iraqi women with breast tumor: A comparative study with Ca 15-3
    Aseel N. Kamil et al, 2021, PROCEEDINGS OF THE III INTERNATIONAL CONFERENCE ON ADVANCED TECHNOLOGIES IN MATERIALS SCIENCE, MECHANICAL AND AUTOMATION ENGINEERING: MIP: Engineering-III – 2021 CrossRef
  18. Levels of Soluble E-Cadherin in Breast, Gastric, and Colorectal Cancers
    Ombretta Repetto et al, 2014, BioMed Research International CrossRef
  19. Prognostic value of vascular endothelial growth factor and hypoxia-inducible factor 1α in canine malignant mammary tumors
    MARINA GOBBE MOSCHETTA et al, 2015, Oncology Reports CrossRef
  20. Protein Array-based Approaches for Biomarker Discovery in Cancer
    Yi Huang et al, 2017, Genomics, Proteomics & Bioinformatics CrossRef